DEF 14A

Company

SELLAS Life Sciences Group, Inc.

Filed

April 30, 2012

Period of Report

June 15, 2012

Accession Number

0001193125-12-195281

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →